MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 172 filers reported holding MERIDIAN BIOSCIENCE INC in Q3 2016. The put-call ratio across all filers is 3.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $217,000 | -63.9% | 14,539 | -65.7% | 0.00% | -66.7% |
Q1 2018 | $601,000 | +233.9% | 42,329 | +225.1% | 0.00% | +200.0% |
Q1 2017 | $180,000 | -29.1% | 13,020 | -9.3% | 0.00% | 0.0% |
Q4 2016 | $254,000 | +17.1% | 14,358 | +28.8% | 0.00% | 0.0% |
Q2 2016 | $217,000 | +325.5% | 11,145 | +309.4% | 0.00% | – |
Q2 2015 | $51,000 | – | 2,722 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SYQUANT CAPITAL SAS | 134,804 | $4,477 | 11.01% |
Vazirani Asset Management LLC | 115,774 | $3,845 | 6.51% |
FIFTH LANE CAPITAL, LP | 185,914 | $6,174,204 | 5.56% |
NEXPOINT ASSET MANAGEMENT, L.P. | 1,939,075 | $64,396,681 | 5.01% |
Crystalline Management Inc. | 244,453 | $8,118,284 | 4.08% |
FNY Investment Advisers, LLC | 51,000 | $1,693 | 2.36% |
HAVENS ADVISORS LLC | 26,800 | $890,028 | 2.26% |
Euclidean Technologies Management, LLC | 62,995 | $2,092,064 | 1.99% |
Sand Grove Capital Management LLP | 537,060 | $17,836 | 1.70% |
Crabel Capital Management, LLC | 120,337 | $3,996 | 1.45% |